Simple quantification of lansoprazole and rabeprazole concentrations in human serum by liquid chromatography/tandem mass spectrometry

J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Jul 1;870(1):38-45. doi: 10.1016/j.jchromb.2008.05.034. Epub 2008 Jun 12.

Abstract

A rapid, simple and highly sensitive method was developed for the quantitative determination of lansoprazole and rabeprazole concentrations in 20 microL of human serum using high-performance liquid chromatography/tandem mass spectrometry (LC/MS/MS). Analytes, along with an internal standard (lansoprazole deuterium derivatives), were separated using a mobile phase of acetonitrile/1mM ammonium formate (140/60, v/v) on a C18 analytical column and analyzed in the selected reaction-monitoring (SRM) mode. The lower limit of quantification was 0.25 ng/mL. A good linear response was observed for each analyte (from 0.25 ng to 2.5 microg/mL). This method was useful for therapeutic drug monitoring and pharmacokinetic studies.

Publication types

  • Evaluation Study

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles / blood*
  • 2-Pyridinylmethylsulfinylbenzimidazoles / chemistry
  • 2-Pyridinylmethylsulfinylbenzimidazoles / pharmacokinetics
  • Chromatography, Liquid / methods*
  • Humans
  • Lansoprazole
  • Male
  • Rabeprazole
  • Sensitivity and Specificity
  • Tandem Mass Spectrometry / methods*

Substances

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Lansoprazole
  • Rabeprazole